account_id none on file
legal_name Nanoviricides, Inc.
ticker NNVC
cik 1379006
domain nanoviricides.com
linkedin_company_url https://www.linkedin.com/company/nanoviricides-inc.
entry_point_account_id none on file
name NanoViricides Inc.
exchange NYSE
sector Health Care
hq Shelton, CT, United States
sector index/company/sector/health-care/
calls 0 filings 3 executives 0 family 0
why_nownone on file
callsnone on file
filings
Our in-house cGMP production capability has resulted in and is expected to continue to result in significant cost savings across all our drug development programs.
filing / May 15, 2026 / receipt
NV-360), and the fully formulated skin cream (the drug product candidate), at our own facilities at ~1Kg scale (API basis) with attendant significant time, project management, and cost savings as opposed to going to an external contract manufacturer.
filing / May 15, 2026 / receipt
Based on this evaluation, our President and our Chief Financial Officer have concluded that the Company’s disclosure controls and procedures are effective as of March 31, 2026.
filing / May 15, 2026 / receipt
executivesnone on file
familynone on file
upcoming
changes
| 2019-02-01 | Chief Executive Officer, departed | sec_8k |
| 2018-09-12 | Director, departed | sec_8k |
| 2018-07-11 | Director, departed | sec_8k |
mcp_package_hint
slug nanoviricides-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$